Nasal spray marketed as a potential drug to kill 99.9 percent of virus particles has begun to remove production lines in an Israeli factory.
The sprayer could prevent many of the world’s COVID-19 diseases, his engineer, Dr. Gilly Regev, told The Times of Israel.
“We hope our nasal sprayer will save many people in countries awaiting vaccination,” said Regev, an Israeli biologist who co-founded the company SaNOtize and developed the spray in Canada. “This will be affordable and can be used for prevention, to protect against any respiratory viral infection.”
Get Israeli Start the Daily Start by Email and Don’t Miss Our Top Stories for Free Sign Up
She said it had been shown to be effective in the laboratory against a wide range of viruses, and said new variants of the coronavirus would not interfere with its effectiveness, confirming: killing all viruses and variants. ”
3D still animated image showing coronavirus structure (https://www.scientificanimations.com/coronavirus-symptoms-and-prevention-explained-through-medical-animation/)
Regev Enovid called it “an equivalent hand sanitizer for the nose,” and said it creates a physical barrier in the nasal passages to stop viruses along with a “chemical barrier”. of nitric oxide, which is known for its antimicrobial effects. “The nitric oxide means that this is a special sprayer that not only inhibits viruses but kills them,” she said.
Israel is the first country where the sprayer will be sold. The Ministry of Health has issued an interim license to sell it as a medical device suitable for people aged 12 and over – meaning many who are not yet licensed for coronavirus vaccines – with a package saying: “Scientific experiment to kill 99.9% of viruses within 2 minutes. ”
Bottle Enovid, a new antiviral nasal spray made in Israel (courtesy of SaNOtize)
It has also been approved for sale in New Zealand, and permission is being sought in other countries, including the UK.
Regev said the factory, in Ness Ziona near Tel Aviv, is working to produce a stock of 200,000 to 500,000 bottles by May. “After this we hope to get to the capacity of a million bottles per month,” a Hebrew University graduate said, adding: “I hope this product will bring pride and jobs to Israel.”
The application on the package is based on a test in laboratories, when a range of live viruses, including influenza and SARS-CoV-2, were brought under the control of the sprayer. She acknowledged that the tests took place outside the human body, in test tubes, and do not provide definitive proof of how effective the spray is in nasal passages – although she said i that they are very confident.
A separate study, not named on the package, has suggested that the sprayer may reduce the effects of COVID-19 among those infected.
Last week, the NHS Foundation Trust of SaNOtize and Ashford and St Peter’s Hospitals in Surrey, UK, published the results of clinical trials showing that the spray could prevent the release of COVID-19, shorten its course, and reduce the severity of symptoms and damage in those. already contagious. The study was submitted to a major medical journal for review and publication.
Family members with safety gear visit a relative at the coronavirus ward of Shaare Zedek hospital in Jerusalem on February 3, 2021 (Yonatan Sindel / Flash90)
The sprayer was fully developed before the pandemic struck, as it was created mainly to fight the flu. His invention is the dosing method for nitric oxide. “It usually comes in gas cylinders and is usually delivered to hospitals, but we wanted a practical way to deliver it as a liquid non-chemical and we are 12 years old. finally spend improving this, “Regev said.
The ingredients of the sprayer mix together when administered to form nitric oxide, she said, noting: “All the components are widely used in the food industry and have a strong safety profile. “Each bottle contains a monthly supply for one person to spray twice a day for virus protection.
She said: “Theoretically we could have it released a year ago, but we had to negotiate a regulatory agreement. That is the biggest frustration, that we have been trying 24/7 for a year to bring it to market, and it could save a lot of lives. I believe it would have prevented disease and thus reduced deaths. “
